Acceleron Pharma Inc. - stock earnings
Stock symbol XLRN is outdated, potentially delisted? Maybe it is available on other exchange?
XLRN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021Q3 | -70.5 million USD | 34.2 million USD |
| 2021Q2 | -63.5 million USD | 27.9 million USD |
| 2021Q1 | -63.5 million USD | 24.8 million USD |
| 2020Q4 | -57.4 million USD | 25.9 million USD |
| 2020Q3 | -39.2 million USD | 22.6 million USD |
| 2020Q2 | -18.5 million USD | 39.8 million USD |
XLRN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -166.0 million USD | 92.5 million USD |
| 2019 | -124.9 million USD | 74.0 million USD |
| 2018 | -118.9 million USD | 14.0 million USD |
| 2017 | -108.5 million USD | 13.5 million USD |
XLRN
Price: $178.75
52 week price:
Earnings Per Share: -2.55 USD
P/E Ratio: -41.22
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 7.9 million
Ebitda: -24.8 millionMarket Capitalization: 10.9 billion